A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease

Acta Radiologica

Volumn 57, Issue 3, 2016, Pages 271-278

  Idilman, Ilkay S ^a   Keskin, Onur ^b   Celik, Azim ^c   Savas, Berna ^b   Elhan, Atilla Halil ^b   Idilman, Ramazan ^b   Karcaaltincaba, Musturay ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c General Electric Healthcare   (Turkey)

Author keywords

Liver biopsy; Magnetic resonance imaging (mri); Magnetic resonance spectroscopy (MRS); Non alcoholic fatty liver disease; Proton density fat fraction (pdff)

Indexed keywords

BIOPSY; EFFICIENCY; HISTOLOGY; MAGNETIC RESONANCE SPECTROSCOPY; MAGNETISM; RESONANCE;

ACCURATE QUANTIFICATIONS; GRADIENT ECHO IMAGING; HEPATIC STEATOSIS; IMAGING METHOD; LIVER BIOPSIES; MAGNETIC RESONANCE SPECTROSCOPIES (MRS); NON-ALCOHOLIC FATTY LIVER DISEASE; PROTON DENSITY;

MAGNETIC RESONANCE IMAGING;

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; PROTON;

ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BODY MASS; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; FAT CONTENT; FATTY LIVER; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEPATITIS; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIVER BIOPSY; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER HISTOLOGY; LIVER INJURY; MAGNETIC RESONANCE IMAGING PROTON DENSITY FAT FRACTION; MALE; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RETROSPECTIVE STUDY; COMPARATIVE STUDY; LIVER; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX;

ADULT; FEMALE; HUMANS; LIVER; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; PROTONS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 84961708259     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1177/0284185115580488     Document Type: Article

References (25)

1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-1231.
2. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology 2003;37:1202-1219.
3. Vuppalanchi R, Chalasani N. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: selected practical issues in their evaluation and management. Hepatology 2009;49:306-317.
4. Ratziu V, Charlotte F, Heurtier A, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005;128:1898-1906.
5. Vuppalanchi R, Unalp A, Natta MV, et al. Increased diagnostic yield from liver biopsy in suspected NAFLD using multiple cores and multiple readings. Gastroenterology 2007;132:809.
6. Schwenzer NF, Springer F, Schraml C, et al. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol 2009;51:433-445.
7. Szczepaniak LS, Nurenberg P, Leonard D, et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 2005;288:462-468.
8. Cowin GJ, Jonsson JR, Bauer JD, et al. Magnetic resonance imaging and spectroscopy for monitoring liver steatosis. J Mag Reson Imaging 2008;28:937-945.
9. Reeder SB, Robson PM, Yu H, et al. Quantification of hepatic steatosis with MRI: The effects of accurate fat spectral modeling. J Mag Reson Imaging 2009;29: 1332-1339.
10. Yokoo T, Bydder M, Hamilton G, et al. Nonalcoholic fatty liver disease: diagnostic fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology 2009;251:67-76.
11. Kim H, Taksali SE, Dufour S, et al. A comparative MR study of hepatic fat quantification using single-voxel proton spectroscopy, two-point Dixon and three-point IDEAL. Magn Reson Med 2008;59:521-527.
12. Meisamy S, Hines CD, Hamilton G, et al. Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: Blinded comparison with MR spectroscopy. Radiology 2011;256: 767-775.
13. Hines CD, Frydrychowicz A, Hamilton G, et al. T(1) independent, T(2) (∗) corrected chemical shift based fatwater separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis. J Magn Reson Imaging 2011;33:873-881.
14. Hu HH, Kim HW, Nayak KS, et al. Comparison of fatwater MRI and single-voxel MRS in the assessment of hepatic and pancreatic fat fractions in humans. Obesity 2010;18:841-847.
15. Tang A, Tan J, Sun M, et al. Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology 2013;267:422-431.
16. Idilman IS, Aniktar H, Idilman R, et al. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. Radiology 2013;267: 767-775.
17. Noureddin M, Lam J, Peterson MR, et al. Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials. Hepatology 2013;58:1930-1940.
18. Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002;123:745-750.
19. Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94:2467-2474.
20. Kleiner DE, Brunt EM, Van Natta ML, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313-1321.
21. Frahm J, Bruhn H, Gyngell ML, et al. Localized highresolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo. Magn Reson Med 1989;9:79-93.
22. Reeder SB, Cruite I, Hamilton G, et al. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Mag Reson Imaging 2011;34: 729-749.
23. Ramalho M, Herédia V, de Campos RO, et al. In-phase and out-of-phase gradient-echo imaging in abdominal studies: intra-individual comparison of three different techniques. Acta Radiol 2012;53:441-449.
24. McPherson S, Jonsson JR, Cowin GJ, et al. Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered. J Hepatol 2009;51:389-397.
25. Kang GH, Cruite I, Shiehmorteza M, et al. Reproducibility of MRI-determined PDFF across two different MR scanner platforms. J Magn Reson Imaging 2011;34:928-934.